Moderna Inc
NASDAQ:MRNA
Moderna Inc
Accumulated Depreciation
Moderna Inc
Accumulated Depreciation Peer Comparison
Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors
Company | Accumulated Depreciation | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Moderna Inc
NASDAQ:MRNA
|
Accumulated Depreciation
-$465m
|
CAGR 3-Years
-51%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Accumulated Depreciation
-$6.7B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-4%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Moderna Inc's Accumulated Depreciation?
Accumulated Depreciation
-465m
USD
Based on the financial report for Mar 31, 2024, Moderna Inc's Accumulated Depreciation amounts to -465m USD.
What is Moderna Inc's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 5Y
-45%
Over the last year, the Accumulated Depreciation growth was 37%. The average annual Accumulated Depreciation growth rates for Moderna Inc have been -51% over the past three years , -45% over the past five years .